Working… Menu

Pilot Study of Growth Hormon to Treat SMA Typ II and III

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00533221
Recruitment Status : Completed
First Posted : September 21, 2007
Last Update Posted : December 18, 2013
Novo Nordisk A/S
Information provided by (Responsible Party):
Janbernd Kirschner, University Hospital Freiburg